BNG.TO Stock News Bengal Energy Ltd. (BNG.TO) 0.50 08/01/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bengal Energy Ltd. (BNG.TO) 0.50 $BNG.TO

Bengal Energy Announces Passing of Director
Marketwire - Mon Jul 07, 4:47PM CDT
Bengal Energy Ltd. (TSX: BNG) ("Bengal" or the "Company" announces with much regret and profound sadness the sudden passing this weekend of Stephen Inbusch, a director of the Company. Mr. Inbusch had been with Bengal since 2012 and was a valued member of the board of directors. He will be missed.

Bengal Energy Announces Fourth Quarter and Record Fiscal 2014 Year End Results
Marketwire - Mon Jun 16, 6:01AM CDT
Bengal Energy Ltd. (TSX: BNG) ("Bengal" or the "Company" is pleased to announce its financial and operating results for the fourth quarter and full year fiscal 2014 results (periods ended March 31, 2014).

Bengal Energy Announces Drilling Results of Koki Exploration Well in Australia's Cooper Basin
Marketwire - Fri Jun 13, 6:01AM CDT
Bengal Energy Ltd. (TSX: BNG) ("Bengal" or the "Company" announces that the Barta Block joint venture, in which the Company holds a 30.4% working interest, has completed drilling operations at Koki-1 (the "Koki-1 Well", the first of two planned exploration wells to be drilled in Bengal's Cuisinier ("ATP" 752P Barta Sub Block within Australia's Cooper Basin. The Koki-1 Well failed to define a commercial hydrocarbon accumulation and has been plugged and abandoned.

Bengal Energy Announces Term Sheet for a US$20 Million Secured Credit Facility and Provides 2014 Cuisinier Exploration Program Update
Marketwire - Tue May 27, 6:02AM CDT
Bengal Energy Ltd. (TSX: BNG) ("Bengal" or the "Company" is pleased to announce that it has signed an indicative term sheet for a US $20.0 million secured credit facility (the "Facility" with a leading Australian commercial bank (the "Lender", and provides an update on its Cuisinier exploration program.

Bengal Energy Reports Significant Increases in Year End Fiscal 2014 Reserves and Value
Marketwire - Tue May 20, 6:02AM CDT
Bengal Energy Ltd. (TSX: BNG) ("Bengal" or the "Company" is pleased to announce significant increases in the net present value and volume of its reserves following the completion of its fiscal 2014 year-end independent reserves report (the "Report". The Report is the result of an independent evaluation of the Company's producing oil and gas properties by GLJ Petroleum Consultants Ltd. ("GLJ" of Calgary, Alberta effective March 31, 2014. The Company's reserves were evaluated by GLJ in compliance with National Instrument 51-101 - Standards of Disclosure for Oil and Gas Activities ("NI 51-101" and in accordance with the Canadian Oil and Gas Evaluation ("COGE" Handbook.

Bengal Energy Announces Largest Drilling Campaign in Company History and Operational Update
Marketwire - Mon Mar 31, 6:02AM CDT
Bengal Energy Ltd. (TSX: BNG) ("Bengal" or the "Company" is pleased to announce the commencement of the largest drilling campaign in the Company's history, with 15 wells planned to be drilled over the next 12 months. Bengal also provides details about this drilling program and an update on its ongoing operations in both Australia and India.

Bengal Energy Announces Third Quarter Fiscal 2014 Results
Marketwire - Wed Feb 12, 4:02PM CST
Bengal Energy Ltd. (TSX: BNG) ("Bengal" or the "Company" is pleased to announce its financial and operating results for the third fiscal quarter of 2014 (period ended December 31, 2013).

Bengal Energy Announces Extension of Maturity Date of $1.75 Million Private Placement Non-Convertible Notes
Marketwire - Fri Jan 24, 4:18PM CST
Bengal Energy Ltd. (TSX: BNG) ("Bengal" or the "Company" today announces that it has agreed with the holders of Bengal's $1,750,000 aggregate principal amount of non-convertible notes ("Non-Convertible Notes" to extend the term of the Non-Convertible Notes from January 24, 2014 to January 24, 2015 and to provide the holders with the right to demand repayment on at least 15 business days prior written notice to Bengal. All of the Non-Convertible Notes are held by insiders of the Company.

Bengal Energy Announces Drilling Results of Tangalooma-1 at Tookoonooka in Australia's Cooper Basin
Marketwire - Thu Jan 02, 5:16PM CST
Bengal Energy Ltd. (TSX: BNG) ("Bengal" or the "Company" announces that Beach Energy Ltd. ("Beach" has completed drilling operations at Tangalooma-1, the first of two fully funded exploration wells to be drilled in Bengal's Tookoonooka block within Australia's Cooper Basin under the Beach joint venture (the "JV". The well failed to define a commercial hydrocarbon accumulation and has been plugged and abandoned.

Bengal Energy Announces Closing of Purchase of Additional Interest in the Cuisinier Oil Field and Operational Update
Marketwire - Wed Dec 18, 7:46PM CST
Bengal Energy Ltd. (TSX: BNG) ("Bengal" or the "Company" is pleased to announce the closing of the previously announced purchase of an additional 5.357% working interest in the Cuisinier Oil Field and Petroleum Lease 303 ('PL303' (the "Acquisition" in the Cooper-Eromanga Basin in Queensland, Australia and to provide an operational update.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Terminus Ballet: A Decade of Defying Dance Norms

Updated Category News Views 135

A Dance Company's Journey of Transformation An anniversary represents more than just a celebration; it's a reminder of the road traveled. On Jan. 30, 2027, Terminus Modern Ballet Theatre will mark its 10th anniversary, encapsulating a decade of defiance against the staid conventions binding classical ballet. This isn't just about pirouettes and pliés—it's dance with a...

Continue Reading
Bacterial Breakthrough in Cancer Therapy: Game Changer?

Updated Category News Views 35

Blurring Lines Between Bugs and Biotech Well, wouldn't you know it, the eggheads over at Jeonbuk National University in South Korea are at it again, pushing the boundaries of what these little bacterial buggers can do. This time, they’ve had a crack at cancer therapy, using engineered Salmonella to pack a double punch against breast cancer in mice. Now, if that ain't...

Continue Reading
Lennar Faces Securities Fraud Lawsuit: Investor Insights

Updated Category News Views 20

Investors in Lennar: Navigating the Legal Storm Hold onto your hats, folks. Lennar Corporation (NYSE: LEN) is up against it with a brand-spanking-new securities fraud lawsuit helmed by Schall, Brown & Schwartz LLP (SBS). This isn't just a couple of investors grumbling over cocktails; it’s a full-blown class action that’s waving the legal banner under the Securities...

Continue Reading
Nauticus Robotics Dive into Defense & UAE Moves

Updated Category News Views 78

Charting New Waters: Defense and UAE Focus Looking at Nauticus Robotics lately, it feels like they're finally getting the hang of balancing their defense play and UAE expansions. This quarter they're coming out swinging, dropping some fine numbers mixed with a slew of strategic moves that got me thinking twice about their place in the subsea robotics world. Financial...

Continue Reading
Tenax Therapeutics Facing Class Action: DEC 28 Deadline

Updated Category News Views 70

Legal Storm Over Tenax Therapeutics Just what the doctor didn't order—legal headaches for Tenax Therapeutics, Inc. (NASDAQ:TENX). Yup, folks, buckle up because we're diving into another class action mudslinging match that’s setting the markets wagging. Berger Montague's law trebuchet is aimed squarely at Tenax and every investor should know the target’s outline....

Continue Reading
Graphic Packaging Shakes Up Leadership and Supply Chain

Updated Category News Views 29

New Leadership Takes the Helm at Graphic Packaging What do you do when you want to streamline an operation that spans continents? Well, if you're Graphic Packaging Holding Company (NYSE: GPK), you bring in fresh leadership to serenade the chaos into a well-oiled machine. Starting December 1, 2026, D. Keith Hamilton will be sinking his teeth into North America Mills &...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 194

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Sasol AGM Resolutions Passed in One Swift Swing

Updated Category News Views 119

Sasol's AGM Delivers Smooth Sailing for Shareholders Can't say I'm surprised, but Sasol's annual general meeting on the 13th of November went off without a hitch—unless, of course, you're one of those folks who just loves fireworks at these gatherings. The entire set of resolutions danced through with a resounding "Aye," making it one heck of a day for anyone banking on...

Continue Reading
ROBOTERA Debuts XHAND 1 Pro-U in NVIDIA Demo

Updated Category News Views 117

ROBOTERA Steps Up with XHAND 1 Pro-U Move over, traditional robotics; ROBOTERA is here to shake things up with their latest marvel, the XHAND 1 Pro-U. This futuristic gadget isn't just making waves at the Conference on Robot Learning (CoRL) where Jim Fan of NVIDIA spotlighted it in his GR00T 2 demo, it's setting a new bar for robotic dexterity. Hand in Glove with Human...

Continue Reading
Saint Luis Rey Launches Exclusive Palatinos Vitola

Updated Category News Views 59

New Beginnings for the Saint Luis Rey Brand You think you've seen it all in the cigar world, but then comes a debut like this that lights a fire under the lush tradition of Cuba. Enter Saint Luis Rey's new Palatinos vitola, a blend wrapped in the mystique of exclusivity for La Casa del Habano and Habanos Specialists. Whether you're a seasoned connoisseur or just dipping...

Continue Reading

Top 5 Most Recently Viewed Articles

Ocuphire Pharma Faces Scrutiny Over Shareholder Obligations

Updated Category News Views 81

Ocuphire Pharma Under Investigation by Ademi LLP Recently, there have been growing concerns regarding the fiduciary responsibilities of Ocuphire Pharma, Inc. (NASDAQ: OCUP) to its public shareholders. Ademi LLP has initiated an investigation focused on whether the company is adequately protecting the interests of its shareholders amidst its dealings with Opus Genetics....

Continue Reading
Investigation Into Shareholder Claims Against AMLX, FIVE, HUM, and VSTS

Updated Category News Views 190

Grabar Law Office Investigates Shareholders' Rights Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), Five Below, Inc. (NASDAQ: FIVE), Humana Inc. (NYSE: HUM), and Vestis Corp. (NYSE: VSTS) shareholders may have claims worth exploring. Grabar Law Office wants to inform these shareholders about the ongoing investigations into potential securities fraud that could have affected...

Continue Reading
Investors Seek Recovery in Class Action Against Paragon 28, Inc.

Updated Category News Views 109

Class Action Lawsuit Filed for Paragon 28, Inc. Investors We are reaching out to inform investors about an important class action securities lawsuit involving Paragon 28, Inc. This initiative aims to recover losses for investors who may have been adversely affected by purported securities fraud associated with the company. Details of the Class Action The class action...

Continue Reading
Alto Ingredients, Inc. Announcement for Q2 2025 Results

Updated Category News Views 165

Alto Ingredients, Inc. to Announce Second Quarter Financial Results Alto Ingredients, Inc. (NASDAQ: ALTO), a prominent producer and distributor of specialty alcohols and renewable fuels, is set to release its financial results for the second quarter of 2025. This announcement will take place after the market closes on Wednesday, August 6, 2025. Conference Call Details...

Continue Reading
Phare Bio Secures $27 Million to Revolutionize Antibiotic Discovery

Updated Category News Views 226

Phare Bio scored big back in 2024 with up to $27 million in funding from the Advanced Research Projects Agency for Health (ARPA-H). This isn’t just pocket change; it’s a lifeline aimed at supercharging their generative artificial intelligence (AI) platform. Teaming up with MIT's Collins Lab and Harvard's Wyss Institute, they set their sights on developing new classes...

Continue Reading